These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

526 related items for PubMed ID: 9198184

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
    Bouma BN, Mosnier LO.
    Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
    [Abstract] [Full Text] [Related]

  • 23. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
    Dusse LM, Cooper AJ, Lwaleed BA.
    Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
    [Abstract] [Full Text] [Related]

  • 24. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
    Binette TM, Taylor FB, Peer G, Bajzar L.
    Blood; 2007 Nov 01; 110(9):3168-75. PubMed ID: 17644733
    [Abstract] [Full Text] [Related]

  • 25. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK, Matijevic-Aleksic N.
    Ann Med; 2000 Dec 01; 32 Suppl 1():73-7. PubMed ID: 11209986
    [Abstract] [Full Text] [Related]

  • 26. Identification and characterisation of monoclonal antibodies that impair the activation of human thrombin activatable fibrinolysis inhibitor through different mechanisms.
    Mishra N, Vercauteren E, Develter J, Bammens R, Declerck PJ, Gils A.
    Thromb Haemost; 2011 Jul 01; 106(1):90-101. PubMed ID: 21544309
    [Abstract] [Full Text] [Related]

  • 27. Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms.
    Zhao L, Morser J, Bajzar L, Nesheim M, Nagashima M.
    Thromb Haemost; 1998 Dec 01; 80(6):949-55. PubMed ID: 9869166
    [Abstract] [Full Text] [Related]

  • 28. [TAFI--thrombin activated fibrinolysis inhibitor ].
    Hryszko T, Małyszko J, Brzósko S, Myśliwiec M.
    Przegl Lek; 2001 Dec 01; 58(3):136-8. PubMed ID: 11475860
    [Abstract] [Full Text] [Related]

  • 29. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP, Blombäck M.
    Thromb Res; 2002 Apr 01; 106(1):59-62. PubMed ID: 12165290
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ, Higuchi DA.
    Blood; 1996 Nov 15; 88(10):3815-23. PubMed ID: 8916945
    [Abstract] [Full Text] [Related]

  • 32. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
    Malyszko J, Malyszko JS, Hryszko T, Mysliwiec M.
    Transplant Proc; 2006 Nov 15; 38(1):105-7. PubMed ID: 16504676
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).
    Boffa MB, Reid TS, Joo E, Nesheim ME, Koschinsky ML.
    Biochemistry; 1999 May 18; 38(20):6547-58. PubMed ID: 10350473
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
    Bajzar L, Jain N, Wang P, Walker JB.
    Crit Care Med; 2004 May 18; 32(5 Suppl):S320-4. PubMed ID: 15118538
    [Abstract] [Full Text] [Related]

  • 36. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 18; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 37. An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma.
    Kim PY, Foley J, Hsu G, Kim PY, Nesheim ME.
    Anal Biochem; 2008 Jan 01; 372(1):32-40. PubMed ID: 17967438
    [Abstract] [Full Text] [Related]

  • 38. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity.
    Zhou X, Weeks SD, Ameloot P, Callewaert N, Strelkov SV, Declerck PJ.
    J Thromb Haemost; 2016 Aug 01; 14(8):1629-38. PubMed ID: 27279497
    [Abstract] [Full Text] [Related]

  • 39. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB, Wang W, Bajzar L, Nesheim ME.
    J Biol Chem; 1998 Jan 23; 273(4):2127-35. PubMed ID: 9442053
    [Abstract] [Full Text] [Related]

  • 40. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T, Marquart JA, Marx PF, Meijers JC.
    J Thromb Haemost; 2015 Nov 23; 13(11):2093-101. PubMed ID: 26341360
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.